{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:40:01Z","timestamp":1739407201271,"version":"3.37.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3472,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1093\/annonc\/mdp453","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T01:57:09Z","timestamp":1256867829000},"page":"1228-1232","source":"Crossref","is-referenced-by-count":4,"title":["Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"G.","family":"Masci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Orefice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zuradelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alloisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Incarbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roncalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2002","series-title":"American Joint Committee on Cancer Staging Manual","author":"Greene","key":"10.1093\/annonc\/mdp453_bb0010"},{"key":"10.1093\/annonc\/mdp453_bb0015","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/cncr.20934","article-title":"Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry","volume":"103","author":"Chagpar","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdp453_bb0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1075-122X.2006.00267.x","article-title":"Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system","volume":"12","author":"Kahn","year":"2006","journal-title":"Breast J"},{"key":"10.1093\/annonc\/mdp453_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/sj.bjc.6600070","article-title":"Occult axillary lymph node metastases are of no prognostic significance in breast cancer","volume":"86","author":"Millis","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdp453_bb0030","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1200\/JCO.2001.19.5.1468","article-title":"Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy","volume":"19","author":"Braun","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jamcollsurg.2007.08.024","article-title":"Significance of sentinel lymph node micrometastases in human breast cancer","volume":"206","author":"Cox","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1093\/annonc\/mdp453_bb0040","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2007.12.6425","article-title":"Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up","volume":"26","author":"Tan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1245\/ASO.2004.10.021","article-title":"Occult micrometastases in axillary lymph node predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up","volume":"11","author":"Susnik","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.suronc.2008.04.006","article-title":"Breast cancer patients with micrometastases only: is a basis provided for tailored treatment?","volume":"17","author":"Grabau","year":"2008","journal-title":"Surg Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.sla.0000150255.30665.52","article-title":"Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy","volume":"241","author":"Viale","year":"2005","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdp453_bb0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.sla.0000216764.16615.8c","article-title":"Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status","volume":"243","author":"Di Tommaso","year":"2006","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdp453_bb0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ejso.2007.07.009","article-title":"The location of small tumor deposits in the SLN predicts Non-SLN macrometastases in breast cancer patients","volume":"34","author":"Li","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0070","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.2005.07.094","article-title":"Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement","volume":"23","author":"Colleoni","year":"2005","journal-title":"J Clin Oncol"},{"year":"2002","series-title":"TNM Classification of Malignant Tumours","author":"Sobin","key":"10.1093\/annonc\/mdp453_bb0075"},{"key":"10.1093\/annonc\/mdp453_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2559.2002.14691.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"41","author":"Elston","year":"2002","journal-title":"Histopathology"},{"year":"1993","series-title":"Tumors of the Mammary Gland","author":"Rosen","key":"10.1093\/annonc\/mdp453_bb0085"},{"key":"10.1093\/annonc\/mdp453_bb0090","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2433::AID-CNCR18>3.0.CO;2-3","article-title":"Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients","volume":"85","author":"Viale","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdp453_bb0095","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/90.21.1601","article-title":"Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer","volume":"90","author":"Goldhirsch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdp453_bb0100","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1200\/JCO.2003.04.576","article-title":"Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer","volume":"21","author":"Goldhirsch","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0105","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","article-title":"Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007","volume":"18","author":"Goldhirsch","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0110","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.1990.8.9.1483","volume":"8","author":"Fisher","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1200\/JCO.1991.9.7.1124","article-title":"Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes","volume":"9","author":"Moliterni","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0120","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2002.06.029","article-title":"American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition","volume":"20","author":"Chlebowski","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp453_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years of adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdp453_bb0130","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp453_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdp453_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1093\/annonc\/mdp453_bb0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.breast.2009.07.003","article-title":"Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy","volume":"18","author":"Garassino","year":"2009","journal-title":"The Breast"},{"key":"10.1093\/annonc\/mdp453_bb0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdp453_bb0155","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-03-0195","article-title":"CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells","volume":"10","author":"Takeuchi","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419392804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419392804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/6\/1228\/445093\/mdp453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:26:42Z","timestamp":1739406402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419392804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0923753419392804"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp453","relation":{},"ISSN":["0923-7534"],"issn-type":[{"type":"print","value":"0923-7534"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}